Prof Daniel Park
Head, Melbourne Bioinformatics Platform
Melbourne Bioinformatics (VLSCI)
108 Scholarly works
22 Projects
HIGHLIGHTS
2025
Journal article
A unifying model for multiple sclerosis
DOI: 10.1007/s10238-025-01666-32025
Journal article
A systematic review and meta-analysis on gene-environment interaction effects on the associations of vitamin D and sun exposure with multiple sclerosis risk
DOI: 10.1016/j.msard.2025.1066342025
Journal article
Genomics reveals zoonotic and sustained human mpox spread in West Africa.
DOI: 10.1038/s41586-025-09128-22025
Journal article
The Germline and Somatic Origins of Prostate Cancer Heterogeneity
DOI: 10.1158/2159-8290.CD-23-08822019
Research Grant
PRECEPT - PRostatE CancEr Prognosis and Treatment
2019
Research grants (other domestic)
PRECEPT - PRostatE CancEr Prognosis and Treatment
2019
Research Grant
The Genomic Drivers of High Risk Prostate Cancer
RECENT SCHOLARLY WORKS
2024
Journal article
Polyphonia: detecting inter-sample contamination in viral genomic sequencing data.
DOI: 10.1093/bioinformatics/btae6982024
Journal article
Prevalence of Germline Pathogenic Variants in Renal Cancer Predisposition Genes in a Population-Based Study of Renal Cell Carcinoma
DOI: 10.3390/cancers161729852024
Journal article
BSBM-04 THE MULTI-OMIC LANDSCAPE OF SOMATIC VARIATION ACROSS A PAN-CANCER COHORT OF BRAIN METASTASES
DOI: 10.1093/noajnl/vdae090.0042024
Journal article
A Family-Based Study of Inherited Genetic Risk in Lipedema
DOI: 10.1089/lrb.2023.00652024
Journal article
Reproductive modes in populations of late-acting self-incompatible and self-compatible polyploid Ludwigia grandiflora subsp. hexapetala in western Europe
DOI: 10.24072/pcjournal.4582024
Journal article
Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants (Nature Medicine, (2022), 28, 5, (1083-1094), 10.1038/s41591-022-01734-1)
DOI: 10.1038/s41591-023-02684-y
RECENT PROJECTS
2021
Research Contracts
PhD Scholarship
2019
Research Grant
PRECEPT - PRostatE CancEr Prognosis and Treatment